Analysis of apoptotic markers Fas/FasL (CD95/CD95L) expression on the lymphocytes in patients with acute coronary syndrome

Kardiologia Polska

Volumn 65, Issue 8, 2007, Pages 883-889

  Bossowska, Anna ^a,c   Bossowski, Artur ^b   Galar, Bogdan ^a  

^a Division of Cardiology   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c Szpital MSWiA   (Poland)

Author keywords

Apoptosis; Myocardial infarction; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FAS ANTIGEN; FAS LIGAND; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; APOPTOSIS; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY RISK; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HYPERTENSION; LYMPHOCYTE; MALE; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; UNSTABLE ANGINA PECTORIS;

EID: 35349027731     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kreuter M, Langer C, Kerkhoff C, et al. Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug development. Arch Immunol Ther Exp (Warsz) 2004; 52: 141-55.
2. Stoneman VE, Bennett MR. Role of apoptosis in atherosclerosis and its therapeutic implications. Clin Scien 2004; 107: 343-54.
3. Kockx MM, Herman AG. Apoptosis in atherogenesis: implications for plaque destabilization. Eur Heart J 1998; 19 Suppl G: G23-8.
4. Fujimoto H, Yamaguchi T. Definition and pathophysiology of acute coronary syndrome. Nippon Rinsho 2006; 64: 611-6.
5. Vaux D, Flavell RA. Apoptosis genes and autoimmunity. Cur Op Immunol 2000; 12: 719-24.
6. Kłyszejko-Stefanowicz L. Cytobiochemia. PZWL, Warszawa 2002; 772-815.
7. Kockx MM, De Meyer GR, Muhring J, et al. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 1998; 97: 2307-15.
8. Sabbah HN. Apoptosis in heart failure: a real problem? Cardiovasc Drug Ther 2001; 15: 525-8.
9. Alber HF, Suessenbacher A, Weidinger F. The role of inflammation in the pathophysiology of acute coronary syndromes. Wien Klin Wochenschr 2005; 13-14: 445-55.
10. Lee P, Sata M, Lefer DJ, et al. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am J Physiol Heart Circ Physiol 2003; 284: 456-63.
11. Pasqui AL, Di Renzo M, Bova G, et al. Lymphocyte apoptosis in non-ST segment elevation acute myocardial infarction. Ann Ital Med Int 2003; 18: 154-61.
12. Li Y, Takemura G, Kosai K, et al. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Circ Res 2004; 95: 627-36.
13. Zhu YZ, Zhu YC, Wang ZJ, et al. Time-dependent apoptotic development and pro-apoptotic genes expression in rat heart after myocardial infarction. Jpn J Pharmacol 2001; 86: 355-8.
14. Huang I, Ito Y, Morikawa M, et al. Bcl-xl gene transfer protects the heart against ischemia/reperfusion injury. Biochem Biophys Res Commun 2003; 311: 64-70.
15. Yang YJ, Chen YF, Ruan YM, et al. Beneficial effects of carvedilol on cardiomyocyte apoptosis and bcl-2/bax expression after acute myocardial infarction an experiment with rats. Zhonghua Yi Xue Za Zhi 2006; 86: 919-22.
16. Chen YF, Yang YJ, Chen X, et al. Effects of atenolol and metoprolol on cardiomyocyte apoptosis and related gene expression after acute myocardial infarction in rats. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006; 28: 538-43.
17. Salvayre R, Auge N, Benoist H, et al. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 2002; 1585: 213-21.
18. Konstadoulakis MM, Kymions GD, Karagiani M. Evidence of apoptosis in human carotid atheroma. J Vasc Surg 1998; 27: 733-9.
19. Okura T, Watanabe S, Jiang Y, et al. Soluble Fas ligand and atherosclerosis in hypertensive patients. J Hypertens 2002; 20: 895-8.